483 Novartis Pharmaceuticals Jan 2017

483 Novartis Pharmaceuticals Jan 2017

Peter Lenahan FDA, Nina Yang FDA$595.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - East Hanover, NJ, United States facility and issued inspectional observations (via FDA 483) on 24 Jan 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Jan 2017
  • Location: East Hanover, United States
  • FEI: 2210396
Add To Cart